Macrophages and dendritic cells have key roles in viral infections, providing virus reservoirs that frequently resist antiviral therapies and linking innate virus detection to antiviral adaptive immune responses 1, 2 . Human immunodeficiency virus 1 (HIV-1) fails to transduce dendritic cells and has a reduced ability to transduce macrophages, due to an as yet uncharacterized mechanism that inhibits infection by interfering with efficient synthesis of viral complementary DNA 3, 4 . In contrast, HIV-2 and related simian immunodeficiency viruses (SIVsm/mac) transduce myeloid cells efficiently owing to their virion-associated Vpx accessory proteins, which counteract the restrictive mechanism 5, 6 . Here we show that the inhibition of HIV-1 infection in macrophages involves the cellular SAM domain HD domain-containing protein 1 (SAMHD1). Vpx relieves the inhibition of lentivirus infection in macrophages by loading SAMHD1 onto the CRL4 DCAF1 E3 ubiquitin ligase, leading to highly efficient proteasome-dependent degradation of the protein. Mutations in SAMHD1 cause Aicardi-Goutières syndrome, a disease that produces a phenotype that mimics the effects of a congenital viral infection 7, 8 . Failure to dispose of endogenous nucleic acid debris in Aicardi-Goutières syndrome results in inappropriate triggering of innate immune responses via cytosolic nucleic acids sensors 9, 10 . Thus, our findings show that macrophages are defended from HIV-1 infection by a mechanism that prevents an unwanted interferon response triggered by self nucleic acids, and uncover an intricate relationship between innate immune mechanisms that control response to self and to retroviral pathogens.
Vpx associates with the DCAF1 substrate receptor subunit (also known as VPRBP) of the cullin 4-based E3 ubiquitin ligase CRL4 DCAF1 (CRL4 DCAF1 is a complex comprising CUL4A-RBX1-DDB1-DCAF1; ref. 11). Failure to infect macrophages and dendritic cells by HIV-2 and SIVmac viruses encoding mutant Vpx proteins deficient in association with this E3 indicated that Vpx usurps CRL4 DCAF1 to overcome the inhibition of infection in myeloid cells 12, 13 . The inhibition of HIV-1 infection in monocyte-derived macrophages (MDM) can be overcome by coinfection with Vpxcontaining SIVsm virus-like particles (SIV VLP) 4, 14 . These SIV VLP do not contain any viral genetic material and can be used to deliver Vpx, which is naturally packaged into virion cores through its interaction with Gag 15, 16 , to target cells. To assess whether Vpx-mediated relief of the inhibition of HIV-1 infection in macrophages is also linked to CRL4
DCAF1
, we coinfected human MDM with vesicular stomatitis virus G (VSV-G)-pseudotyped HIV-1 NL4-3-derived single cycle reporter virus encoding the green fluorescent protein (GFP) reporter (HIV-1-GFP) in the presence of VSV-G-pseudotyped SIV VLP loaded with HIV-2 Rod Vpx (SIV VLP(Vpx)) or with a Vpx variant (Vpx Q76A ) that does not bind to DCAF1 (ref. 12). Wild-type Vpx greatly enhanced MDM transduction by HIV-1-GFP, whereas the Vpx Q76A did not have such a stimulatory effect (Fig. 1a) , and viral cDNA synthesis was inefficient both in the absence of Vpx and upon coinfection with Vpx Q76A (Fig. 1b) , as also observed with vpx-defective single-cycle HIV-2-GFP and SIVmac-GFP reporter viruses 12 (Supplementary Fig. 1 ). This evidence supports the model in which Vpx relieves the inhibition of HIV-1 infection in MDM by targeting an unknown antiviral inhibitory protein for proteasome-dependent degradation, through the CRL4 DCAF1 E3 ubiquitin ligase. To identify Vpx-recruited substrates for the CRL4 DCAF1 ubiquitin ligase, a proteomic screen was used to search for the cellular protein(s) that associate with the CRL4 DCAF1 complex only in the presence of Vpx. Specifically, we directed the assembly of three sets of protein complexes in HEK 293T cells for their subsequent proteomic characterization (Fig. 2a) The most abundant of the candidate proteins uncovered in this screen was the innate immune SAM-domain HD-domain containing protein 1 (SAMHD1), which copurified with both Vpx (6 spectra) and Vpx-CRL4 DCAF1 complex (37 spectra), but not with CRL4 DCAF1 complex alone (Supplementary Table 1 ). Interestingly, SAMHD1 mutations are associated with Aicardi-Goutières syndrome, an autoimmune disease caused by an abnormal innate immune response to endogenous nucleic acids 7, 8 . Besides SAMHD1, approximately 150 cellular proteins were found associated with cullin 4 in the presence of Vpx. Because these proteins were low quality hits represented by three or fewer spectra, and/or were found previously to be frequent contaminants, they were not considered to be viable candidates.
To assess whether SAMHD1 binding and recruitment to the DCAF1-linked complex are conserved functions of Vpx, we investigated HIV-2 Rod Vpx, which, as SIVmac 239 Vpx, is also functional 6, 12, 13 . As a negative control we selected the Vpr accessory proteins of HIV-1 and SIVmac, because they are closely related to Vpx, sharing roughly 25% and 50% amino acid identity, and can load cellular substrate proteins onto CRL4 DCAF1 (ref. 21) but, unlike Vpx, Vpr does not alleviate the inhibition of lentivirus infection in MDM. Human epitope-tagged SAMHD1 was coexpressed with Vpx, or Vpr, in HEK 293T cells and Vpx/Vpr immune complexes were analysed by western blotting. SAMHD1 coprecipitated efficiently with both Vpx variants, but not with Vpr (Fig. 2b) . Next, we confirmed that Vpx specifically links SAMHD1 to the CRL4 DCAF1 E3 complex. SAMHD1 was coexpressed with wild-type SIVmac Vpx, a Vpx Q76A variant that does not bind DCAF1, or HIV-1 Vpr that does not bind SAMHD1, in HEK 293T cells. Analysis of SAMHD1 immune complexes showed that SAMHD1 directed assembly of a protein complex containing Vpx, and the DCAF1 and DDB1 subunits of the CRL4 DCAF1 complex (Fig. 2c ). In contrast, neither Vpx Q76A , which had reduced binding to SAMHD1, nor Vpr, formed such complexes. We conclude that Vpx specifically binds to, and recruits SAMHD1 to the DCAF1-DDB1 module of CRL4 DCAF1 E3 ubiquitin ligase. Because SAMHD1 was originally identified in HEK 293T cells, it was important to confirm that it is both expressed and targeted by Vpx for degradation via CRL4 DCAF1 in MDM. We therefore performed western blot analysis of MDM lysates and measured steady state SAMHD1 levels following MDM infection with SIV VLP loaded with either Vpx or the Vpx Q76A variant control (Fig. 3a) . We observed that wild-type Vpx readily depleted endogenous SAMHD1 levels. In contrast, Vpx Q76A , which is defective for DCAF1 binding 12 , did not decrease SAMHD1 levels. Importantly, the effect of Vpx was blocked when macrophages were exposed to the proteasome inhibitor MG132 before and during infection with Vpx-loaded SIV VLP (Fig. 3b) . We conclude that Vpx programs SAMHD1 for destruction in MDM.
Our above biochemical and functional studies with Vpx Q76A variants indicated that Vpx uses the CRL4 DCAF1 E3 ubiquitin ligase to program SAMHD1 degradation. To test this directly, we first depleted the DCAF1 subunit of CRL4 DCAF1 by RNA interference (RNAi), and then characterized the effects of this knockdown on Vpx-mediated SAMHD1 depletion in MDM. MDM were transfected with siRNA targeting DCAF1 or with non-targeting control siRNAs (NT1, NT2). DCAF1-specific siRNA caused a large reduction in DCAF1 levels (Fig. 3c) . Two days after the initiation of RNAi, the cells were infected with Vpx-loaded SIV VLP and the SAMHD1 levels were assessed 2 days later. In the absence of Vpx (Fig. 3c , left panel) there was no significant change in SAMHD1 levels following treatment with either the DCAF1 or control siRNAs. Significantly, Vpx induced an almost complete degradation of SAMHD1 in cells treated with the control siRNAs. By contrast, in the DCAF1-depleted cells degradation of SAMHD1 induced by Vpx was significantly inhibited, providing further evidence for our hypothesis that Vpx uses CRL4 DCAF1 E3 to program SAMHD1 degradation.
Then we set out to investigate the role of SAMHD1 in HIV-1 infection in MDM. Unfortunately, RNAi-mediated knockdown of SAMHD1 was only weakly effective in MDM (Fig. 3c, left panel) . We believe that SAMHD1 levels in MDM are resistant to depletion by RNAi because the half-life of SAMHD1 is long, and RNAi can only prevent new protein synthesis; thus, due to slow turnover rate, it cannot achieve depletion of existing SAMHD1 protein. Hence, we developed a two-step protocol to manipulate SAMHD1 levels over a wide concentration range by using a combination of RNAi and SIV VLP to deliver to cells low doses of Vpx. In the first step, macrophages were infected with low doses of Vpx-loaded SIV VLP to deplete the pre-existing SAMHD1 pool. In the second step we blocked SAMHD1 re-synthesis by RNAi. 
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As shown in Fig. 4 , freshly isolated CD14 1 monocytes grown in the presence of macrophage colony-stimulating factor (M-CSF) were infected with increasing, but suboptimal, doses of Vpx-loaded SIV VLP. RNAi targeted to SAMHD1 or a non-targeting RNAi was initiated 4 days later. Three days after the initiation of RNAi the macrophages were challenged with HIV-1-GFP reporter virus. We observed that RNAi to SAMHD1 stimulated MDM transduction by several fold, compared to non-targeting RNAi, throughout the entire titration range for Vpx, and the permissiveness to HIV-1-GFP transduction showed good, but not simple, inverse correlation with SAMHD1 levels in MDM (Fig. 4a, b , see also Supplementary Figs 2,  3 and 4) . The most dramatic increases in MDM permissiveness were revealed at low doses of Vpx that on their own barely stimulated HIV-1 transduction. Quantification of viral reverse transcription intermediates showed that depleting SAMHD1 levels stimulated synthesis of viral full-length cDNA by approximately tenfold (Fig. 4c) , and again this effect was well pronounced even at the lowest doses of Vpx. Specifically, it can be clearly seen that the 'early' (E) versus 'late' (L) cDNA PCR readouts showed selective repression of 'late' reverse transcription products at high but not low SAMHD1 levels. Furthermore, MDM transduction by Vpx-defective HIV-2 vpx2 -GFP and SIVmac vpx2 -GFP reporter constructs was also enhanced up to 12-fold, by siRNA to SAMHD1 (Fig. 4d) . This evidence clearly demonstrates that SAMHD1 inhibits MDM infection by HIV-1 and other primate lentiviruses by disrupting synthesis of viral cDNA.
In summary, our results show that SAMHD1 interferes with HIV infection of macrophages by preventing efficient viral cDNA synthesis. The Vpx accessory protein of HIV-2/SIVsm lineage viruses removes this inhibition by targeting SAMHD1 for proteasome-dependent degradation via CRL4 DCAF1 E3 ubiquitin ligase ( Supplementary Fig. 5 ). Because HIV-2 and related simian viruses have evolved the Vpx function to counteract SAMHD1, they are able to infect macrophages much more readily than HIV-1. Indeed, vpx-deficient SIVsm/mac viruses are attenuated in simian models of acquired immunodeficiency syndrome (AIDS), and show evidence for defective macrophage-dependent dissemination at early stages of infection and the apparent absence of macrophage-driven encephalitis at later stages 22, 23 . Our discovery that the SAMHD1 protein inhibits HIV infection in macrophages unveils a novel and unexpected link between unconventional cell-intrinsic innate immune mechanisms and the antiviral defence. Notably, in addition to SAMHD1, two nucleases, TREX1 and RNase H2, have been linked to Aicardi-Goutières syndrome 8 . Recent studies of TREX1 suggest that it has a role in the control of ). c, Vpx depletes SAMHD1 levels in MDM via DCAF1. MDM were subjected to RNAi targeting DCAF1, SAMHD1 or non-targeting RNAi (NT1, NT2), and infected (1) or not (2) with SIV VLP loaded with SIVmac Vpx, 2 days later. DCAF1 and SAMHD1 were revealed by western blotting after an additional 2 days.
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retrotransposon and endogenous retroviral elements, and in inhibiting the innate immune response to HIV-1 DNA in T cells and macrophages by clearing excess of viral cDNA 9, 24 . However, the reported effects of TREX1 on HIV-1 were not associated with an overt restriction of HIV-1 infection in either cell type, in contrast to our findings with SAMHD1.
One unanswered question is how myeloid cell specificity of SAMHD1-mediated inhibition of HIV-1 infection is achieved? SAMHD1 is expressed in HEK 293T cells, undifferentiated THP-1 cells and other non-myeloid cell types that do not possess a Vpx-sensitive mechanism restricting primate lentivirus infection ( Supplementary  Figs 6 and 7) . One possible explanation is that SAMHD1-mediated restriction may require a myeloid cell-specific molecule. Alternatively, cell-type-specific differences in early post-entry events involved in viral core uncoating and/or reverse transcription complex function may make HIV/SIV prone to SAMHD1 specifically in myeloid cells 25, 26 . Of note, we observed that SAMHD1 levels are depleted by Vpx in both MDM and monocyte-derived dendritic cells in a Vpx Q76-dependent manner (data not shown) involving SAMHD1 as the key AicardiGoutières syndrome protein inhibiting lentivirus infection in myeloid cells. Whether SAMHD1 functions autonomously, what are the other key components of a putative SAMHD1 pathway, and what are the salient features of SAMHD1 that endow this protein with anti-HIV activity, require further investigation.
METHODS SUMMARY
Blood from adult healthy volunteer donors was collected at Case CFAR Clinical Core according to an Institutional Review Board (IRB) approved protocol. Monocytes isolated from peripheral blood mononuclear cells by positive selection for CD14 using CD14 microbeads (Miltenyi Biotec) were differentiated into macrophages by culturing in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum (FBS), 10 ng ml 21 macrophagecolony stimulating factor (M-CSF, R&D Systems) for the first 2 days and 20 ng ml 21 thereafter, in 24-well plates at 3.0 3 10 5 -3.5 3 10 5 cells per well. Cells were fed every alternate day by replacing one half of the cell culture medium with fresh medium.
Purity of CD14
1 cells obtained by positive selection usually ranged between 95% and 99% whereas the final purity of the adherent macrophage population was typically greater than 99%. Infections were carried out between day 6 and day 9. Flow cytometry analysis of GFP expression was performed 3 to 4 days post infection. MDM were detached from wells by trypsin treatment, resuspended in PBS containing 1% FBS, fixed by addition of paraformaldehyde to 1% and GFP expression analysed by flow cytometry.
METHODS
Expression plasmids. pCG plasmids expressing epitope-tagged DCAF1, DDB1, wild-type and mutant HIV-2 Rod and SIVmac 239 Vpx proteins were previously described 20 . Human SAMHD1 protein coding sequence was amplified by PCR from an EST clone (MHS1010-7295666, Open Biosystems) using 59-GGAAGAA TCTAGAATGCAGCGAGCCGATTCCG-39 and 59-GGAAGAAACGCGTCACA TTGGGTCATCTTTAAAAAGCTGG-39 primers and subcloned into pCG vectors encoding amino-terminal epitope tags. Single cycle proviral reporter constructs. HIV-1-derived single cycle pHR'-EGFP-IRES-nef proviral clone and SIVmac 239 (GFP) reporter viruses, kindly provided by J. Karn and F. Kirchhoff, respectively, were previously described 12, 27 . HIV-2 Rod GFP proviral clone was constructed by M. Emerman and kindly provided by N. Manel 6, 28 . SIVmac 251 virus-like particles (SIV VLP) for Vpx delivery were produced using the SIV31 plasmid, provided by A. Cimarelli 3 .
The vpx gene in the SIV31 plasmid was inactivated by converting its initiation codon to a stop codon to give SIV31 vpx-, using Quikchange XLII kit (Stratagene). . Virus-and SIV VLP-containing cell culture media were collected 1 day after transfection, treated with DNase I (Roche) at 20 U ml 21 , for 20 min at 30 uC and virions were concentrated and partially purified by pelleting through 20% sucrose in TNE buffer (10 mM Tris-HCl pH 7.4, 100 mM NaCl, 1 mM EDTA) cushion, for 3 h at 30,000 r.p.m., 4 uC in a SW32TI rotor 16 . Virion pellets were suspended in 1% of the original volume of TNE, aliquoted, and stored at 280 uC. Virus preparations were normalized on the basis of their infectivities to HEK 293T and/or Jurkat T cells. SIV VLP were normalized by western blotting for p27 capsid and/or Vpx. Monocyte-derived macrophage culture. Blood from adult healthy volunteer donors was collected at Case CFAR Clinical Core. Monocytes isolated from peripheral blood mononuclear cells by positive selection for CD14 using CD14 microbeads (Miltenyi Biotec) were differentiated into macrophages by growing in DMEM supplemented with 10% heat-inactivated fetal bovine serum (FBS), 2 mM glutamine, 100 U ml 21 penicillin G, 100 mg ml 21 streptomycin, 10 ng ml 1 cells obtained by positive selection usually ranged between 95% and 99%, whereas the final purity of the adherent macrophage population was typically greater than 99%. Infections were carried out between day 6 and day 9. Flow cytometry analysis of GFP expression was performed 3 to 4 days post infection. Macrophages were detached from wells by trypsin treatment, resuspended in PBS containing 1% FBS, fixed by addition of paraformaldehyde to 1% and GFP fluorescence analysed by flow cytometry. Transient expression assays and immunoprecipitations. HEK 293T cells were transfected with pCG plasmids expressing proteins of interest by calcium phosphate coprecipitation method. Detergent extracts and anti-Flag immune complexes were prepared and analysed by immunoblotting as previously described 20 . Antibodies and immunoblot analyses. Antibodies against human SAMHD1 and a-tubulin were purchased from Sigma-Aldrich. Antibodies against DCAF1, DDB1, Vpx (6D2.6), SIVmac 251 capsid (13-112-100), and those against Flag (M2), HA (12CA5) and Myc (9E10) epitopes were previously described 12, 20 . For western blot analyses, proteins were separated by SDS-PAGE, transferred to PVDF membrane (Millipore) in a semi-dry blotter (Bio-Rad), incubated with appropriate primary and secondary antibodies, and immune complexes visualized by enhanced chemiluminescence (GE Healthcare), as previously described 12, 20 . Immunoaffinity purifications of protein complexes and MudPIT analyses. Protein complexes were purified from HEK 293T cells transiently expressing epitope tagged subunits. The Flag-cullin 4-DDB1(DDA1)-HA-DCAF1 complex was purified from HEK 293T cells transiently expressing Flag-cullin 4 and HA-DCAF1. The Flag-cullin 4-DDB1(DDA1)-DCAF1-HA-Vpx complex was purified from HEK 293T cells transiently expressing Flag-cullin 4 and HA-Vpx. Protein complexes were purified by two sequential precipitations via HA and then Flag epitope tags, each followed by competitive elution with the respective epitope peptide under native conditions, from approximately 3 g of wet cell mass. MudPIT analyses of purified protein complexes were performed as we previously described 20 . Distributed normalized spectral abundance factors (dNSAF) were calculated for each detected protein as described Depletion of SAMHD1 by Vpx-loaded SIV VLP and siRNA. CD14 1 monocytes were isolated and grown as described above, and infected with various doses of Vpx-loaded SIV VLP 2 days after plating. On day 6, adherent macrophages were transfected with siRNA, using Lipofectamine 2000. Two to three days following the initiation of RNAi cells were collected for immunoblot analyses, or infected with reporter viruses. Cells were collected 1 day post-infection for real-time analysis of viral cDNA synthesis, or 3 days post-infection for flow cytometry analysis of GFP fluorescence in the infected cells. For studies with proteasome inhibitor MG132, MDM were grown in the presence or absence of MG132 (1 mg ml 21 ) for 1 h and then infected with threefold dilutions of SIVmac Vpx-loaded SIV VLP for an additional 3 h, in the continuous presence or absence of MG132, and collected for western blot analysis of SAMHD1 levels. Real-time PCR. Reverse transcription products were quantified using the Bio-Rad MyiQ Single-Color Real-Time PCR Detection System. A typical reaction contained 50 ng of DNA isolated with a DNeasy Kit (Qiagen) from infected or control cells and SYBR Green PCR master mix (Applied Biosystems) in a total volume of 25 ml. HIV-1 HR reverse transcription products were amplified with ert2f and ert2r (early), and MH532 and MH531 (late), primers as previously described 30 . The levels of reverse transcription products were calculated by comparison to standard curves generated with serially diluted proviral clones. The variances between triplicate data points were less than 5%. 
